cancer

Studies show that the risk of breast cancer can be reduced by half through the use of a five-year course of tamoxifen or raloxifene and[...]

A new Mayo Clinic study suggests that some patients with pancreatic cancer could increase survival with adjustments to their chemotherapy regimen before surgery. Historically, most[...]

As I write this message, the snow has finally stopped in Minnesota and the month of May is upon us — a time each year[...]

Mayo Clinic researchers have found that the oral drug apixaban is safe and effective to treat blood clots in patients undergoing cancer therapy. Apixaban was[...]

Yi Lin, M.D., Ph.D., a hematologist at Mayo Clinic in Rochester, Minnesota, talks about her cellular therapy research.

Treating breast cancer has long involved addressing two problems: the elimination of cancer cells from the tumor and potential disease recurrence. The key may be[...]

Roxana S. Dronca, M.D., a hematologist and an oncologist at Mayo Clinic in Jacksonville, Florida, discusses her research on tumor immunology, malignant melanoma and genitourinary malignancies.

Stephen M. Ansell, M.D., Ph.D., a hematologist at Mayo Clinic in Rochester, Minnesota, discusses his lymphoma research.

Amylou C. Dueck, Ph.D., a Mayo Clinic biostatistician in Scottsdale, Arizona, discusses her work as director of the Cancer Center's Biostatistics Shared Resource.

Keith L. Knutson, Ph.D., an immunologist at Mayo Clinic's campus in Florida and a professor in the Mayo Clinic College of Medicine and Science, discusses his research on the immunology and immunotherapy of breast cancer and ovarian cancer.